Four key notes:
1. Stryker has an aggressive acquisition strategy that prizes add-ons to fit into its existing business so the company can strengthen its position in all lines. “We want to be absolute leaders in the field,” Mr. Lobo said at the event.
2. Research and development is an important aspect of the company’s acquisitions to ensure the technology is sound. Mr. Lobo reported Stryker spends around 6.5 percent of revenue on R&D, according to the report.
3. Mr. Lobo prizes de-risked buys and would rather spend extra on acquiring technology he knows will work and then apply Stryker’s expertise to scale manufacturing.
4. Finally, Mr. Lobo attributed the company’s success to the autonomy he gives divisional leaders to innovate and identify the best deals to present at headquarters.
More articles on orthopedics:
Medicare’s bundled payments cut joint replacement spending by 1.6% — 5 study takeaways
Wisconsin health system settles orthopedic surgeon’s kickback violation allegations for $10M: 5 details
NYC orthopedic surgeon’s office manager alleges doctor set her up for grand larceny arrest, charges: 5 details
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.